Paper Details

  1. Home
  2. Paper Details

Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials.

Author: FischerA, ScheuchG, SiekmeierR, StegemannJ

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review describes the principles and advances of individualized controlled inhalation (ICI) as offered by the AKITA inhalation system. The AKITA inhalation system enables more efficient and targeted drug delivery to the lungs, resulting in shorter treatment times, better reproducibility of administered lung doses, and fewer side effects. It also leads to improved quality of life, compliance, and reduced patient numbers needed for clinical trials.
Paper Details　
Original Abstract of the Article :
In the treatment of pulmonary diseases the inhalation of aerosols plays a key role - it is the preferred route of drug delivery in asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. But, in contrast to oral and intravenous administration drug delivery to the lungs is controlle...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521343/

データ提供：米国国立医学図書館（NLM）

Novel Inhalation Devices for Pulmonary Diseases: Improving Treatment in the Desert of Respiratory Health

Pulmonary diseases, a vast and complex landscape, require innovative treatment approaches. This study explores the potential of novel inhalation devices for optimizing aerosol therapy in pulmonary diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. The researchers examine the advancements in inhalation technology that allow for individualized controlled inhalation (ICI), enabling more precise drug delivery and improved treatment outcomes.

Optimizing Aerosol Therapy: A Breath of Fresh Air in the Desert of Respiratory Health

This study highlights the potential of ICI to enhance the efficacy of aerosol therapy in pulmonary diseases. By enabling more precise drug delivery and shorter treatment times, ICI can potentially improve patient outcomes and quality of life.

Navigating the Desert of Respiratory Health with Precision

This research underscores the importance of individualized treatment approaches in pulmonary diseases. By considering the unique characteristics of each patient and utilizing advanced inhalation technologies, healthcare providers can optimize treatment outcomes and improve patient well-being.

Dr.Camel's Conclusion

This study offers a promising glimpse into the future of respiratory health care. Novel inhalation devices have the potential to revolutionize treatment for pulmonary diseases, providing a more efficient and effective way to deliver medication directly to the lungs.

Date :
  1. Date Completed 2010-08-10
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

20156730

DOI: Digital Object Identifier

PMC3521343

Related Literature

Article Analysis
・Side Effects of budesonide oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.